These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38791162)

  • 21. Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity.
    Xian Z; Tian J; Zhao Y; Yi Y; Li C; Han J; Zhang Y; Wang Y; Wang L; Liu S; Pan C; Liu C; Wang D; Meng J; Tang X; Wang F; Liang A
    Phytomedicine; 2023 Jun; 114():154815. PubMed ID: 37062136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse.
    Rosenquist TA
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1360-7. PubMed ID: 21429970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease.
    Dieter BP; Meek RL; Anderberg RJ; Cooney SK; Bergin JL; Zhang H; Nair V; Kretzler M; Brosius FC; Tuttle KR
    PLoS One; 2019; 14(2):e0211555. PubMed ID: 30763329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A kidney injury molecule-1 (Kim-1) gene reporter in a mouse artificial chromosome: the responsiveness to cisplatin toxicity in immortalized mouse kidney S3 cells.
    Kokura K; Kuromi Y; Endo T; Anzai N; Kazuki Y; Oshimura M; Ohbayashi T
    J Gene Med; 2016 Oct; 18(10):273-281. PubMed ID: 27591740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute nephrotoxicity of aristolochic acids in mice.
    Sato N; Takahashi D; Chen SM; Tsuchiya R; Mukoyama T; Yamagata S; Ogawa M; Yoshida M; Kondo S; Satoh N; Ueda S
    J Pharm Pharmacol; 2004 Feb; 56(2):221-9. PubMed ID: 15005881
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Kawasaki H; Murakami T; Badr Y; Kamiya S; Shimizu K; Okada A; Inoshima Y
    Exp Lung Res; 2020 Nov; 46(9):352-361. PubMed ID: 32842790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice.
    Urate S; Wakui H; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Taguchi S; Tsukamoto S; Kinguchi S; Uneda K; Kanaoka T; Atobe Y; Funakoshi K; Yamashita A; Tamura K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway.
    Wang X; Xue N; Zhao S; Shi Y; Ding X; Fang Y
    Cell Death Dis; 2020 Aug; 11(8):620. PubMed ID: 32796834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition.
    Zhang N; Ahsan MH; Purchio AF; West DB
    J Immunol; 2005 Jun; 174(12):8125-34. PubMed ID: 15944321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.
    Hiratsuka S; Watanabe A; Sakurai Y; Akashi-Takamura S; Ishibashi S; Miyake K; Shibuya M; Akira S; Aburatani H; Maru Y
    Nat Cell Biol; 2008 Nov; 10(11):1349-55. PubMed ID: 18820689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse.
    Mailhiot SE; Zignego DL; Prigge JR; Wardwell ER; Schmidt EE; June RK
    PLoS One; 2015; 10(7):e0130564. PubMed ID: 26151638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic induction of mouse serum amyloid A3 promoter by the inflammatory mediators IL-1 and IL-6.
    Huang JH; Liao WS
    J Interferon Cytokine Res; 1999 Dec; 19(12):1403-11. PubMed ID: 10638709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
    Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
    Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy.
    Wee YM; Go H; Choi MY; Jung HR; Cho YM; Kim YH; Han DJ; Shin S
    BMB Rep; 2019 Sep; 52(9):554-559. PubMed ID: 31072444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway.
    Wu J; Liu X; Fan J; Chen W; Wang J; Zeng Y; Feng X; Yu X; Yang X
    Toxicology; 2014 Apr; 318():22-31. PubMed ID: 24530882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.
    Chen SM; Fan MY; Tseng CC; Ho Y; Hsu KY
    Toxicon; 2007 Aug; 50(2):180-8. PubMed ID: 17512963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.
    Shibutani S; Bonala RR; Rosenquist T; Rieger R; Suzuki N; Johnson F; Miller F; Grollman AP
    Int J Cancer; 2010 Sep; 127(5):1021-7. PubMed ID: 20039324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats.
    Hu X; Shen J; Pu X; Zheng N; Deng Z; Zhang Z; Li H
    Toxicol Sci; 2017 Mar; 156(1):123-132. PubMed ID: 28115647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion of serum amyloid A3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice.
    den Hartigh LJ; Wang S; Goodspeed L; Ding Y; Averill M; Subramanian S; Wietecha T; O'Brien KD; Chait A
    PLoS One; 2014; 9(9):e108564. PubMed ID: 25251243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum amyloid A3 is pro-atherogenic.
    Thompson JC; Wilson PG; Shridas P; Ji A; de Beer M; de Beer FC; Webb NR; Tannock LR
    Atherosclerosis; 2018 Jan; 268():32-35. PubMed ID: 29175652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.